Avalia Immunotherapies

Avalia Immunotherapies is a company that develops immune system modulators and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapies are designed to target the liver and spleen to modulate a more potent and targeted immune response against certain viruses and cancers. The company focuses on a range of therapeutic areas, including chronic hepatitis B, malaria, influenza, virus-associated cancers, and solid tumors.